ArticleCureus2025
Primary High-Grade Diffuse Large B-Cell Lymphoma of the Cecum: A Report of a Rare Case.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary diffuse large B-cell lymphoma (DLBCL) of the colon is rare and most commonly involves the cecum due to its rich lymphoid tissue. Diagnosis is often delayed because symptoms are nonspecific and endoscopic biopsies may be inconclusive. We report a case of high-grade cecal DLBCL in a 22-year-old male patient who presented with right-sided abdominal pain, weight loss, intermittent fever, and night sweats over three months. Examination revealed a palpable right iliac fossa mass, and imaging demonstrated a large cecal lesion with regional lymphadenopathy; however, colonoscopic biopsies were nondiagnostic. The patient underwent right hemicolectomy, and histopathology with immunohistochemistry confirmed high-grade DLBCL (CD20+, CD10+, BCL6+, Ki-67 ≈ 80%). Postoperatively, he developed a wound infection that was managed conservatively before initiating chemotherapy. This case illustrates that, despite its rarity and diagnostic challenges, cecal DLBCL can be successfully treated through a multidisciplinary approach. Clinicians should consider lymphoma in the differential diagnosis of cecal masses in young adults, particularly when B symptoms are present or biopsy results are inconclusive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.